PG
Patten Group Portfolio holdings
AUM
$473M
1-Year Return
16.66%
This Quarter Return
+6.72%
1 Year Return
+16.66%
3 Year Return
+66.29%
5 Year Return
+111.01%
10 Year Return
+232.25%
AUM
$262M
AUM Growth
+$12.6M
(+5.1%)
Cap. Flow
-$1.69M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
743
New
71
Increased
136
Reduced
160
Closed
50
Top Buys
Top Sells
| 1 |
Vulcan Materials
VMC
|
$1.4M |
| 2 |
Norfolk Southern
NSC
|
$1.26M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$650K |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$649K |
| 5 |
Hanesbrands
HBI
|
$414K |
Sector Composition
| 1 | Financials | 11.64% |
| 2 | Technology | 10.97% |
| 3 | Industrials | 10.38% |
| 4 | Consumer Staples | 10.05% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
American International
AIG
$43.9B
| $323K | 0.12% |
6,075
-6,309
| -51% | -$335K |
|
152
Philip Morris
PM
$251B
| $323K | 0.12% |
3,964
+15
| +0.4% | +$1.22K |
|
153
iShares 7-10 Year Treasury Bond ETF
IEF
$35.9B
| $319K | 0.12% |
3,156
-912
| -22% | -$92.2K |
|
154
Illumina
ILMN
$15.7B
| $318K | 0.12% |
889
| – | – |
|
155
Applied Materials
AMAT
$130B
| $313K | 0.12% |
8,091
-8,149
| -50% | -$315K |
|
156
Bristol-Myers Squibb
BMY
$96B
| $309K | 0.12% |
4,973
+6
| +0.1% | +$373 |
|
157
Labcorp
LH
$23.2B
| $308K | 0.12% |
2,064
+216
| +12% | +$32.2K |
|
|
SPLK
158
DELISTED
Splunk Inc
SPLK
| $300K | 0.11% |
2,479
+110
| +5% | +$13.3K |
|
159
iShares Select Dividend ETF
DVY
$20.8B
| $299K | 0.11% |
2,996
-40
| -1% | -$3.99K |
|
160
General Dynamics
GD
$86.8B
| $297K | 0.11% |
1,451
-300
| -17% | -$61.4K |
|
161
General Mills
GIS
$27B
| $297K | 0.11% |
6,915
| – | – |
|
162
Sempra
SRE
$52.9B
| $294K | 0.11% |
5,170
| – | – |
|
163
Industrial Select Sector SPDR Fund
XLI
$23.1B
| $287K | 0.11% |
3,666
+160
| +5% | +$12.5K |
|
164
Avanos Medical
AVNS
$590M
| $285K | 0.11% |
+4,155
| New | +$285K |
|
165
Duke Energy
DUK
$93.8B
| $282K | 0.11% |
3,523
+290
| +9% | +$23.2K |
|
166
iShares Biotechnology ETF
IBB
$5.8B
| $281K | 0.11% |
2,307
| – | – |
|
167
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.15B
| $280K | 0.11% |
3,352
+240
| +8% | +$20K |
|
168
Accenture
ACN
$159B
| $279K | 0.11% |
1,640
+30
| +2% | +$5.1K |
|
169
Bank of Montreal
BMO
$90.3B
| $272K | 0.1% |
3,298
| – | – |
|
170
Starbucks
SBUX
$97.1B
| $272K | 0.1% |
4,780
-1,570
| -25% | -$89.3K |
|
171
Hilton Worldwide
HLT
$64B
| $268K | 0.1% |
3,322
-530
| -14% | -$42.8K |
|
172
iShares Intermediate Government/Credit Bond ETF
GVI
$3.55B
| $262K | 0.1% |
2,440
-250
| -9% | -$26.8K |
|
173
iShares Core S&P US Growth ETF
IUSG
$24.6B
| $261K | 0.1% |
4,205
+560
| +15% | +$34.8K |
|
174
AbbVie
ABBV
$375B
| $260K | 0.1% |
2,749
-115
| -4% | -$10.9K |
|
175
iShares Russell 1000 ETF
IWB
$43.4B
| $251K | 0.1% |
1,555
+694
| +81% | +$112K |
|